Fig. 4From: Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries – a model-based cost-effectiveness analysisTotal cost and quality-adjusted life years gained through screening and treatment for LTBI among 15- to 34-year-old asylum seekers arriving in Germany in 2022. Small circles show single model iterations; large circles denote mean estimates. *The incidence threshold denotes the country-of-origin TB incidence level above which asylum seekers would become eligible for LTBI screening and TPTBack to article page